STOCK TITAN

Nicholas Peters holds 1,161,049 shares of QHSLab (USAQ), 8.65% stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

QHSLab, Inc. reports a Schedule 13G showing beneficial ownership of 8.65% represented by 1,161,049 shares of Common Stock. The filing lists Nicholas Peters as the beneficial owner with sole and shared voting and dispositive power over 1,161,049 shares.

The filing is signed by Nicholas Peters and dated 02/09/2026.

Positive

  • None.

Negative

  • None.

Insights

Single investor reports an 8.65% stake with full voting and dispositive authority.

The filing shows Nicholas Peters beneficially owns 1,161,049 shares, representing 8.65% of the class, and lists both sole and shared voting and dispositive power for the same amount. This indicates control claims over the position rather than passive custody.

Timing is explicit: the signature date is 02/09/2026. Future disclosures may clarify whether this stake is held for investment or other purposes.

A disclosed 8.65% holding could be noticeable for float and block trading considerations.

The excerpt quantifies the position as 1,161,049 common shares and repeats the voting/dispositive counts identically, suggesting consolidated control. The cash‑flow treatment or planned transactions are not described in the excerpt.

Market impact depends on the company's float and subsequent filings; watch for any Form 4 or Schedule 13D amendments that change intent or activity.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Nicholas Peters
Signature:/s/ Nicholas Peters
Name/Title:Nicholas Peters/Private Investor
Date:02/09/2026

FAQ

How many QHSLab (USAQ) shares does Nicholas Peters report owning?

The filing states 1,161,049 shares of Common Stock, representing 8.65% of the class as reported in the Schedule 13G dated 02/09/2026. The same share count is used for voting and dispositive power.

Does the Schedule 13G for QHSLab (USAQ) show voting or disposition authority?

Yes. The filing lists sole and shared voting power of 1,161,049 shares and sole and shared dispositive power of 1,161,049, all attributed to Nicholas Peters.

What date is on the QHSLab (USAQ) Schedule 13G filing by Nicholas Peters?

The Schedule 13G is signed and dated 02/09/2026 by Nicholas Peters. The filing shows ownership and authority figures tied to that date.

Is the reported stake in QHSLab (USAQ) a majority or minority position?

The reported holding is a minority position of 8.65% of the class, based on the disclosed 1,161,049 shares. The filing does not state any majority control or complete ownership.

Where is QHSLab's principal office listed in the filing?

The filing lists the issuer's principal executive offices at 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407 as part of the Schedule 13G issuer information.
QHSLab Inc

OTC:USAQ

USAQ Rankings

USAQ Latest News

USAQ Latest SEC Filings

USAQ Stock Data

1.81M
11.14M
Medical Devices
Healthcare
Link
United States
West Palm Beach